Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival:
Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial
To access this article, please choose from the options below
PII: S0002-8703(08)00054-9
doi:10.1016/j.ahj.2008.01.008
© 2008 Mosby, Inc. All rights reserved.
